Meropenem Steriscience (Meropenem)

Meropenem Steriscience is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections across several organ systems.

• Complicated intra‑abdominal infections: effective against severe intra‑abdominal infections caused by susceptible organisms.
• Complicated urinary tract infections: clears resistant urinary pathogens in complicated cases.
• Bacterial meningitis: penetrates the cerebrospinal fluid to treat meningitis caused by susceptible bacteria.
• Sepsis: provides rapid bactericidal activity in systemic infections.
• Pneumonia: treats hospital‑acquired and ventilator‑associated pneumonia caused by resistant strains.

• Meropenem inhibits bacterial cell wall synthesis by binding with high affinity to penicillin‑binding proteins, disrupting peptidoglycan cross‑linking. This leads to loss of cell wall integrity and bacterial lysis, providing a bactericidal effect against a wide range of Gram‑positive, Gram‑negative and anaerobic organisms.

Adverse reactions may occur with meropenem therapy and are categorized by frequency and severity.

Common Side Effects

• Nausea
• Diarrhea
• Rash
• Headache
• Elevated liver enzymes
• Injection site reactions

Serious or Rare Side Effects

• Seizures, especially in patients with CNS disorders
• Clostridioides difficile‑associated colitis
• Anaphylaxis or severe hypersensitivity reactions
• Severe neutropenia or leukopenia
• Renal toxicity or worsening renal function
• Severe skin reactions such as Stevens‑Johnson syndrome

Clinicians should consider several precautions when prescribing meropenem.

• Renal function: adjust dose in patients with impaired renal function.
• Allergy: avoid in patients with known hypersensitivity to carbapenems or other beta‑lactams.
• Seizure risk: monitor patients with a history of seizures or central nervous system disorders.
• Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
• Antibiotic stewardship: limit use to confirmed infections to reduce resistance development.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Valproic acid: may increase risk of seizures.
• Phenobarbital: may reduce meropenem effectiveness.
• Probenecid: may raise meropenem plasma concentrations.
• CNS depressants: additive seizure risk.
• Nephrotoxic agents: heightened risk of renal injury.

Moderate Interactions (Monitor Closely)

• Aminoglycosides: combined nephrotoxicity.
• Loop diuretics: may affect renal clearance.
• Warfarin: monitor INR for anticoagulation changes.
• Oral contraceptives: possible reduction in contraceptive efficacy.
• Immunosuppressants: increased infection risk, monitor closely.